1-(14-methyl-6,10,13-triazatetracyclo[7.7.0.02,6.011,16]hexadeca-1(9),11(16),12,14-tetraen-10-yl)-2-pyridin-3-ylpropan-2-ol

C22H26N4O — CID 71007637

IUPAC1-(14-methyl-6,10,13-triazatetracyclo[7.7.0.02,6.011,16]hexadeca-1(9),11(16),12,14-tetraen-10-yl)-2-pyridin-3-ylpropan-2-ol
SMILESCc1cc2c3c(n(CC(C)(O)c4cccnc4)c2cn1)CCN1CCCC31
InChIInChI=1S/C22H26N4O/c1-15-11-17-20(13-24-15)26(14-22(2,27)16-5-3-8-23-12-16)19-7-10-25-9-4-6-18(25)21(17)19/h3,5,8,11-13,18,27H,4,6-7,9-10,14H2,1-2H3
InChIKeyCOBRNTAFJWBMFD-UHFFFAOYSA-N
MW362.48 g/mol
LogP3.34
Rot. Bonds3

About 1-(14-methyl-6,10,13-triazatetracyclo[7.7.0.02,6.011,16]hexadeca-1(9),11(16),12,14-tetraen-10-yl)-2-pyridin-3-ylpropan-2-ol

1-(14-methyl-6,10,13-triazatetracyclo[7.7.0.02,6.011,16]hexadeca-1(9),11(16),12,14-tetraen-10-yl)-2-pyridin-3-ylpropan-2-ol (PubChem CID 71007637) has the molecular formula C22H26N4O and a molecular weight of 362.48 g/mol. Its IUPAC name is 1-(14-methyl-6,10,13-triazatetracyclo[7.7.0.02,6.011,16]hexadeca-1(9),11(16),12,14-tetraen-10-yl)-2-pyridin-3-ylpropan-2-ol.

Molecular Properties

Compound Name1-(14-methyl-6,10,13-triazatetracyclo[7.7.0.02,6.011,16]hexadeca-1(9),11(16),12,14-tetraen-10-yl)-2-pyridin-3-ylpropan-2-ol
PubChem CID71007637
Molecular FormulaC22H26N4O
Molecular Weight362.48 g/mol
Exact Mass362.21
IUPAC Name1-(14-methyl-6,10,13-triazatetracyclo[7.7.0.02,6.011,16]hexadeca-1(9),11(16),12,14-tetraen-10-yl)-2-pyridin-3-ylpropan-2-ol
SMILESCc1cc2c3c(n(CC(C)(O)c4cccnc4)c2cn1)CCN1CCCC31
InChIInChI=1S/C22H26N4O/c1-15-11-17-20(13-24-15)26(14-22(2,27)16-5-3-8-23-12-16)19-7-10-25-9-4-6-18(25)21(17)19/h3,5,8,11-13,18,27H,4,6-7,9-10,14H2,1-2H3
InChIKeyCOBRNTAFJWBMFD-UHFFFAOYSA-N
XLogP3.34
TPSA54.18 Ų
H-Bond Donors1
H-Bond Acceptors5
Rotatable Bonds3
Heavy Atoms27
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500362.48
LogP ≤ 53.34
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 105

Analyze 1-(14-methyl-6,10,13-triazatetracyclo[7.7.0.02,6.011,16]hexadeca-1(9),11(16),12,14-tetraen-10-yl)-2-pyridin-3-ylpropan-2-ol with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 1-(14-methyl-6,10,13-triazatetracyclo[7.7.0.02,6.011,16]hexadeca-1(9),11(16),12,14-tetraen-10-yl)-2-pyridin-3-ylpropan-2-ol?
The IUPAC name of 1-(14-methyl-6,10,13-triazatetracyclo[7.7.0.02,6.011,16]hexadeca-1(9),11(16),12,14-tetraen-10-yl)-2-pyridin-3-ylpropan-2-ol (CID 71007637) is 1-(14-methyl-6,10,13-triazatetracyclo[7.7.0.02,6.011,16]hexadeca-1(9),11(16),12,14-tetraen-10-yl)-2-pyridin-3-ylpropan-2-ol.
What is the SMILES notation for 1-(14-methyl-6,10,13-triazatetracyclo[7.7.0.02,6.011,16]hexadeca-1(9),11(16),12,14-tetraen-10-yl)-2-pyridin-3-ylpropan-2-ol?
The canonical SMILES for 1-(14-methyl-6,10,13-triazatetracyclo[7.7.0.02,6.011,16]hexadeca-1(9),11(16),12,14-tetraen-10-yl)-2-pyridin-3-ylpropan-2-ol is Cc1cc2c3c(n(CC(C)(O)c4cccnc4)c2cn1)CCN1CCCC31.
What is the InChIKey of 1-(14-methyl-6,10,13-triazatetracyclo[7.7.0.02,6.011,16]hexadeca-1(9),11(16),12,14-tetraen-10-yl)-2-pyridin-3-ylpropan-2-ol?
The InChIKey is COBRNTAFJWBMFD-UHFFFAOYSA-N. The full InChI is InChI=1S/C22H26N4O/c1-15-11-17-20(13-24-15)26(14-22(2,27)16-5-3-8-23-12-16)19-7-10-25-9-4-6-18(25)21(17)19/h3,5,8,11-13,18,27H,4,6-7,9-10,14H2,1-2H3.
What are the key properties of 1-(14-methyl-6,10,13-triazatetracyclo[7.7.0.02,6.011,16]hexadeca-1(9),11(16),12,14-tetraen-10-yl)-2-pyridin-3-ylpropan-2-ol?
1-(14-methyl-6,10,13-triazatetracyclo[7.7.0.02,6.011,16]hexadeca-1(9),11(16),12,14-tetraen-10-yl)-2-pyridin-3-ylpropan-2-ol has a molecular weight of 362.48 g/mol, XLogP of 3.34, 3 rotatable bonds, 1 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for 1-(14-methyl-6,10,13-triazatetracyclo[7.7.0.02,6.011,16]hexadeca-1(9),11(16),12,14-tetraen-10-yl)-2-pyridin-3-ylpropan-2-ol is sourced from PubChem (CID 71007637), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).